Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bavarian Nordic ADR (BVNRY)

Bavarian Nordic ADR (BVNRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bavarian Nordic ADR Philip Heymans Alle 3 Hellerup G7 2900 DNK

www.bavarian-nordic.com P: 45-3326-8383

Description:

Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical trial stage. Bavarian Nordic A/S is headquartered in Kvistgaard, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 1,621,315
Enterprise Value, $K 1,698,795
Shares Outstanding, K 234,294
Annual Sales, $ 1,025 M
Annual Net Income, $ 214,090 K
Last Quarter Sales, $ 353,270 K
Last Quarter Net Income, $ 130,120 K
EBIT, $ 85,480 K
EBITDA, $ 46,510 K
60-Month Beta 1.50
% of Institutional Shareholders 0.00%
Float, K 234,294
% Float 100.00%
Short Volume Ratio 0.07

Growth:

1-Year Return -20.29%
3-Year Return -35.93%
5-Year Return -32.49%
5-Year Revenue Growth 1,192.51%
5-Year Earnings Growth 316.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.56 on 03/06/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm 1.30
EPS Growth vs. Prev Qtr 300.00%
EPS Growth vs. Prev Year 460.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 3-1 on 01/20/16

BVNRY Ratios

Ratio
Price/Earnings ttm 5.50
Price/Earnings forward 13.75
Price/Earnings to Growth N/A
Return-on-Equity % 0.07%
Return-on-Assets % 14.62%
Profit Margin % 20.89%
Debt/Equity 0.00
Price/Sales 1.63
Price/Cash Flow 206.74
Price/Book 1.23
Book Value/Share 5.83
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar